Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Asthma
Interventions
DRUG

Formatris 24µg

12µg Formoterol Novolizer#1 + 12µg Formoterol Novolizer#2 + Placebo Aerolizer#1 + Placebo Aerolizer #2

DRUG

Formatris 12µg

12µg Formoterol Novolizer#1 + Placebo Novolizer#2 + Placebo Aerolizer#1 + Placebo Aerolizer #2

DRUG

Foradil P 24µg

Placebo Novolizer#1 + Placebo Novolizer#2 + 12µg Formoterol Aerolizer#1 + 12µg Formoterol Aerolizer #2

DRUG

Foradil P 12µg

Placebo Novolizer#1 + Placebo Novolizer#2 + 12µg Formoterol Aerolizer#1 + Placebo Aerolizer #2

Trial Locations (3)

52242

University of Iowa, Iowa City

53705

University of Wisconsin, Madison

32160-0486

University of Florida, Gainesville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ClinResearch, GmbH

OTHER

collaborator

Trio Clinical Research, LLC, Raleigh, USA

UNKNOWN

collaborator

NuCara Pharmacy, Waterloo, USA

UNKNOWN

collaborator

Prof. Hochhaus, Gainesville, USA

UNKNOWN

lead

MEDA Pharma GmbH & Co. KG

INDUSTRY